XNYS · Medical Devices
Last stored close · Nov 10, 2026
Close · Nov 10, 2026
$257.12+0.07%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
56/100
Positive
Score components
TickerWhale View
Steris scores 56 out of 100 overall, which we rate positive. Technical is its strongest area and Quality & growth its weakest.
What helps
- Technical
- Valuation
- Risk
What to watch
- Quality & growth
Quality & growth
30%26Weak
- Revenue growth 8.4%
- EPS growth 25.3%
Valuation
25%52Moderate
- P/E 31.3
- EV/Sales 4.4
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
#403 by market cap in our coverage · ~17,937 employees · Listed 1992-06-02 · www.steris.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
#70 / 139sector rank by TickerWhale Score
TickerWhale Score 56 vs sector average 54.6 (+1.4)
Revenue growth (industry)Top 72%
Gross margin (industry)Top 94%
Return on equity (industry)Top 39%
P/E (industry)Pricier than 53%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
93/100Strong vs universe
Ranks 93rd of 100 covered names on our technical composite — the composite itself scores 82/100 · 25% of the TickerWhale Score
Classic chart indicators
Buy
5 buy · 3 sell · 0 neutral of 8 votes
TickerWhale rates STE's technical setup strong — 93rd percentile of the covered universe. Classic chart indicators lean buy, pointing the same way.
Moving averages
9 / 9constructive
- vs 200-day+14.7%
- vs 50-day+16.1%
Momentum
Weak
- RSI (14)75 · sell
- Stochasticsell
- CCIbuy
- Williams %Rsell
Trend
Constructive
- ADX (14) trend strength44· trending
- MACD (12,26,9)buy(histogram 2.885)
How the classic verdict is reached
Moving averages (9) agree on buy — 9 buy vs 0 sell — and carry one vote between them.
Oscillators (7) vote individually: 4 buy · 3 sell · 0 neutral.
Result — 5 buy vs 3 sell of 8 votes = Buy. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-11-10 · revised_latestValuation multiples
- P/E (TTM)31.3
- P/S (TTM)4.2
- P/B3.5
- EV/EBITDA—
- EV/Sales4.4
- PEG1.24
Profitability & returns
- Gross margin44.4%
- Net margin13.3%
- ROE11.2%
- Debt/Equity0.26
Growth
- Revenue growth (YoY)8.4%
- EPS growth (YoY)25.3%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $25.2B
Fundamentals history
Reported statement totals across recent periods.
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: KNSA →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STECurrentSteris | 56 | 82 | 31.3 | — | 3.5 | 4.4 | $257.12 | +0.07% | +8.4% | ||
| EXELExelixis | 82 | 88 | 21.3 | — | 9.9 | 7.4 | $70.58 | -1.62% | +9.2% | ||
| KNSAKiniksa Pharmaceuticals International plc. - | 79 | 81 | 98.2 | — | 12.1 | 9.3 | $95.02 | -3.79% | +58.9% | ||
| THCTenet Healthcare | 79 | 81 | 10.9 | — | 5.2 | 1.6 | $290.27 | +0.44% | +7.5% | ||
| INCYIncyte | 76 | 67 | 15.5 | — | 3.9 | 3.6 | $120.30 | -1.30% | +26.9% | ||
| LIVNLivaNova | 76 | 84 | 27.2 | — | 3.9 | 3.3 | $91.14 | -1.59% | +12.4% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.